Published in Mech Dev on March 01, 2001
Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS One (2007) 2.77
Mutation of melanosome protein RAB38 in chocolate mice. Proc Natl Acad Sci U S A (2002) 2.02
Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor. J Cell Biol (2002) 2.00
Mesenchymal-epithelial interactions in the skin: increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation. J Cell Biol (2004) 1.56
Sequential actions of Pax3 and Pax7 drive xanthophore development in zebrafish neural crest. Dev Biol (2008) 1.55
Pax genes in embryogenesis and oncogenesis. J Cell Mol Med (2008) 1.37
Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease. Pigment Cell Melanoma Res (2008) 1.35
The secreted metalloprotease ADAMTS20 is required for melanoblast survival. PLoS Genet (2008) 1.34
Melanocytes in development and cancer. J Cell Physiol (2010) 1.15
Targeting Wnt pathways in disease. Cold Spring Harb Perspect Biol (2012) 1.11
PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas). PLoS One (2010) 1.10
MITF and cell proliferation: the role of alternative splice forms. Pigment Cell Res (2005) 1.10
Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice. Hum Mol Genet (2009) 1.09
Functional melanocytes derived from human pluripotent stem cells engraft into pluristratified epidermis. Proc Natl Acad Sci U S A (2011) 1.04
PAX3 expression in primary melanomas and nevi. Mod Pathol (2008) 1.01
A dual role for SOX10 in the maintenance of the postnatal melanocyte lineage and the differentiation of melanocyte stem cell progenitors. PLoS Genet (2013) 0.99
Differentiated melanocyte cell division occurs in vivo and is promoted by mutations in Mitf. Development (2011) 0.97
Fascin 1 is transiently expressed in mouse melanoblasts during development and promotes migration and proliferation. Development (2013) 0.96
Melanoma biomolecules: independently identified but functionally intertwined. Front Oncol (2013) 0.95
GSK-3 promotes cell survival, growth, and PAX3 levels in human melanoma cells. Mol Cancer Res (2012) 0.92
Pax3 and Zic1 drive induction and differentiation of multipotent, migratory, and functional neural crest in Xenopus embryos. Proc Natl Acad Sci U S A (2013) 0.90
PAX3 mutations and clinical characteristics in Chinese patients with Waardenburg syndrome type 1. Mol Vis (2010) 0.84
Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors. Nat Commun (2014) 0.82
Allele-specific genetic interactions between Mitf and Kit affect melanocyte development. Pigment Cell Melanoma Res (2010) 0.82
Hearing dysfunction in heterozygous Mitf(Mi-wh) /+ mice, a model for Waardenburg syndrome type 2 and Tietz syndrome. Pigment Cell Melanoma Res (2012) 0.81
Insights into the Role of PAX-3 in the Development of Melanocytes and Melanoma. Open Cancer J (2011) 0.81
Embryonic corneal Schwann cells express some Schwann cell marker mRNAs, but no mature Schwann cell marker proteins. Invest Ophthalmol Vis Sci (2009) 0.81
A new transgenic mouse line for tetracycline inducible transgene expression in mature melanocytes and the melanocyte stem cells using the Dopachrome tautomerase promoter. Transgenic Res (2010) 0.80
Extrafollicular dermal melanocyte stem cells and melanoma. Stem Cells Int (2012) 0.80
Does melanoma begin in a melanocyte stem cell? J Skin Cancer (2012) 0.79
Postnatal lineage mapping of follicular melanocytes with the Tyr::CreER(T) (2) transgene. Pigment Cell Melanoma Res (2012) 0.78
Polycomb group proteins--epigenetic repressors with emerging roles in melanocytes and melanoma. Pigment Cell Melanoma Res (2015) 0.77
Regional Fluctuation in the Functional Consequence of LINE-1 Insertion in the Mitf Gene: The Black Spotting Phenotype Arisen from the Mitfmi-bw Mouse Lacking Melanocytes. PLoS One (2016) 0.75
Role of EZH2 histone methyltrasferase in melanoma progression and metastasis. Cancer Biol Ther (2016) 0.75
Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence. Dermatol Clin (2017) 0.75
Should we consider cancers as embryonic diseases or as consequences of stem-cell deregulation? Clin Med Oncol (2008) 0.75
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (1984) 24.45
Coincidence of the promoter and capped 5' terminus of RNA from the adenovirus 2 major late transcription unit. Cell (1978) 9.60
Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses. Genes Dev (1988) 7.52
Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature (1993) 7.41
In vitro transcription of adenovirus. J Virol (1981) 7.06
Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell (1991) 5.76
Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription. Mol Cell Biol (1986) 5.07
Promoters and heterogeneous 5' termini of the messenger RNAs of adenovirus serotype 2. J Mol Biol (1981) 5.01
Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells. J Biol Chem (1985) 4.87
Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science (1991) 4.45
Determination of the nucleotide sequence of a fragment of bacteriophage phiX 174 DNA. Nat New Biol (1973) 3.74
Mutation of the c-fos gene dyad symmetry element inhibits serum inducibility of transcription in vivo and the nuclear regulatory factor binding in vitro. Mol Cell Biol (1987) 3.53
HeLa cell beta-tubulin gene transcription is stimulated by adenovirus 5 in parallel with viral early genes by an E1a-dependent mechanism. Mol Cell Biol (1984) 3.44
Transcription and RNA processing by the DNA tumour viruses. Nature (1980) 3.25
Transcripts from the adenovirus-2 major late promoter yield a single early family of 3' coterminal mRNAs and five late families. Cell (1980) 3.21
c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J (1994) 3.01
Stimulation of neuronal acetylcholine receptors induces rapid gene transcription. Science (1986) 2.43
PICK1 targets activated protein kinase Calpha to AMPA receptor clusters in spines of hippocampal neurons and reduces surface levels of the AMPA-type glutamate receptor subunit 2. J Neurosci (2001) 2.39
Mutagenesis reveals a role for ABP/GRIP binding to GluR2 in synaptic surface accumulation of the AMPA receptor. Neuron (2000) 2.32
The AMPA receptor GluR2 C terminus can mediate a reversible, ATP-dependent interaction with NSF and alpha- and beta-SNAPs. Neuron (1998) 2.25
Novel anchorage of GluR2/3 to the postsynaptic density by the AMPA receptor-binding protein ABP. Neuron (1998) 2.06
Microinjection of fos-specific antibodies blocks DNA synthesis in fibroblast cells. Mol Cell Biol (1988) 2.00
Mitochondrial encephalomyopathies: biochemical studies in two cases revealing defects in the respiratory chain. Brain (1982) 1.80
Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol Cell Biol (1990) 1.75
CCAAT/enhancer binding protein-alpha amino acid motifs with dual TBP and TFIIB binding ability co-operate to activate transcription in both yeast and mammalian cells. EMBO J (1995) 1.70
Development and transferability of a cost-effective laparoscopic camera navigation simulator. Surg Endosc (2004) 1.70
Three levels of functional interaction determine the activity of CCAAT/enhancer binding protein-alpha on the serum albumin promoter. Genes Dev (1994) 1.65
Biogenesis, structures, and sites of encoding of the 5' termini of adenovirus-2 mRNAs. Cold Spring Harb Symp Quant Biol (1980) 1.52
Synaptophysin regulates clathrin-independent endocytosis of synaptic vesicles. Proc Natl Acad Sci U S A (2000) 1.50
Repression of insulin gene expression by adenovirus type 5 E1a proteins. Mol Cell Biol (1987) 1.50
Vector expression of adenovirus type 5 E1a proteins: evidence for E1a autoregulation. Mol Cell Biol (1985) 1.49
Purification of mature-stage Plasmodium falciparum by gelatine flotation. Ann Trop Med Parasitol (1994) 1.47
Toxic effects of human eosinophil products on isolated rat heart cells in vitro. Biochem J (1982) 1.46
Identification and characterization of mRNAs regulated by nerve growth factor in PC12 cells. Mol Cell Biol (1987) 1.42
NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1. J Neurosci (1995) 1.41
Desorption-ionization mass spectrometry using deposited nanostructured silicon films. Anal Chem (2001) 1.39
Adenovirus E1a proteins repress expression from polyomavirus early and late promoters. Mol Cell Biol (1986) 1.36
The amino-terminal region of the adenovirus serotype 5 E1a protein performs two separate functions when expressed in primary baby rat kidney cells. Mol Cell Biol (1988) 1.34
A new bind for Myc. Trends Genet (1992) 1.34
A nerve growth factor-regulated messenger RNA encodes a new intermediate filament protein. J Cell Biol (1988) 1.30
Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. J Neurosci (1997) 1.26
Biochemical adaptation in the skeletal muscle of rats depleted of creatine with the substrate analogue beta-guanidinopropionic acid. Biochem J (1985) 1.25
Complementary functions of E1a conserved region 1 cooperate with conserved region 3 to activate adenovirus serotype 5 early promoters. J Virol (1994) 1.21
Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions. Genes Dev (1992) 1.21
Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells. Oncogene (1987) 1.19
Post-transcriptional regulation of synaptic vesicle protein expression and the developmental control of synaptic vesicle formation. J Neurosci (1997) 1.17
DNA-binding motif. Nature (1989) 1.16
Myc represses transcription of the growth arrest gene gas1. Proc Natl Acad Sci U S A (1997) 1.13
Mbh 1: a novel gelsolin/severin-related protein which binds actin in vitro and exhibits nuclear localization in vivo. EMBO J (1991) 1.11
Nerve growth factor regulates tyrosine hydroxylase gene transcription through a nucleoprotein complex that contains c-Fos. Genes Dev (1990) 1.09
Transcription activation by serum, PDGF, and TPA through the c-fos DSE: cell type specific requirements for induction. Oncogene (1989) 1.08
Chemical transformation of 4-thiouracil nucleosides to uracil and cytosine counterparts. J Am Chem Soc (1968) 1.06
Mxi1 is a repressor of the c-Myc promoter and reverses activation by USF. J Biol Chem (1999) 1.06
AMPA receptor subunit GluR1 downstream of D-1 dopamine receptor stimulation in nucleus accumbens shell mediates increased drug reward magnitude in food-restricted rats. Neuroscience (2009) 1.06
An investigation of arterial insufficiency in rat hindlimb. A combined 31P-n.m.r. and bloodflow study. Biochem J (1986) 1.04
Consistent and selective expression of the discoidin domain receptor-1 tyrosine kinase in human brain tumors. Neurosurgery (2000) 1.04
Poly(A) sites of adenovirus serotype 2 transcription units. J Mol Biol (1982) 1.04
Raf phosphorylates p53 in vitro and potentiates p53-dependent transcriptional transactivation in vivo. Oncogene (1995) 1.02
Structure of the gene encoding peripherin, an NGF-regulated neuronal-specific type III intermediate filament protein. Neuron (1989) 1.01
Adenovirus 5 E1A proteins disrupt the neuronal phenotype and growth factor responsiveness of PC12 cells by a conserved region 1-dependent mechanism. Oncogene (1993) 1.01
Functional analysis of an isolated fos promoter element with AP-1 site homology reveals cell type-specific transcriptional properties. Mol Cell Biol (1990) 0.99
Selective inhibition of adenovirus type 2 early region II and III transcription by an anisomycin block of protein synthesis. Mol Cell Biol (1982) 0.98
Dominant negative mutants of Myc inhibit cooperation of both Myc and adenovirus serotype-5 E1a with Ras. J Cell Physiol (1996) 0.95
Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells. Oncogene Res (1989) 0.94
The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner Max. Mol Cell Biol (1995) 0.93
Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways. J Neurovirol (2013) 0.92
AP-1, CREB and CBP transcription factors differentially regulate the tyrosine hydroxylase gene. Brain Res Mol Brain Res (1998) 0.92
Role of NMDA receptor functional domains in excitatory cell death. Neuropharmacology (2000) 0.92
Mitochondrial myopathies: defects in mitochondrial metabolism in human skeletal muscle. Biochem Soc Trans (1983) 0.92
Genetic elements regulating HES-1 induction in Wnt-1-transformed PC12 cells. Cell Growth Differ (1998) 0.91
Nerve growth factor regulates the expression and activity of p33cdk2 and p34cdc2 kinases in PC12 pheochromocytoma cells. Mol Biol Cell (1994) 0.91
Mitochondrial myopathies: disorders of the respiratory chain and oxidative phosphorylation. J Inherit Metab Dis (1984) 0.90
Myoadenylate deaminase deficiency or not? Observations on two brothers with exercise-induced muscle pain. J Neurol Sci (1982) 0.90
A mitochondrial encephalomyopathy. A combined 31P magnetic resonance and biochemical investigation. J Neurol Sci (1985) 0.89
The expression of the neuronal intermediate filament protein peripherin in the rat embryo. Brain Res Dev Brain Res (1990) 0.89
The adenovirus-5 12S E1a protein, but not the 13S induces expression of the endoA differentiation marker in F9 cells. Oncogene (1989) 0.88
Novel toxicity of the unedited GluR2 AMPA receptor subunit dependent on surface trafficking and increased Ca2+-permeability. Mol Cell Neurosci (2007) 0.88
A colorimetric method for the determination of lipoxygenase activity suitable for use in a high throughput assay format. Anal Biochem (1995) 0.87
Pediatric brain tumors express multiple receptor tyrosine kinases including novel cell adhesion kinases. Pediatr Neurosurg (1996) 0.87
Altered expression of helix-loop-helix transcriptional regulators and cyclin D1 in Wnt-1-transformed PC12 cells. Cell Growth Differ (1998) 0.86
Cell-density-dependent regulation of expression and glycosylation of dopachrome tautomerase/tyrosinase-related protein-2. J Invest Dermatol (2000) 0.86
Experimentally induced defects of mitochondrial metabolism in rat skeletal muscle. Biological effects of the mitochondrial uncoupling agent 2,4-dinitrophenol. Biochem J (1985) 0.86
Elevated c-myc expression in childhood medulloblastomas. Pediatr Res (1990) 0.85
Dynamic interactions of c-fos protein in serum-stimulated 3T3 cells. J Cell Physiol (1989) 0.85
ABP: a novel AMPA receptor binding protein. Ann N Y Acad Sci (1999) 0.84
A new mitochondrial myopathy. Biochemical studies revealing a deficiency in the cytochrome b-c1 complex (complex III) of the respiratory chain. Brain (1984) 0.84
Cyclin D2 and Ha-Ras transformed rat embryo fibroblasts exhibit a novel deregulation of cell size control and early S phase arrest in low serum. EMBO J (1995) 0.83
Comparative acute oral toxicity of para-aminopropiophenone (PAPP) in mammals and birds. Bull Environ Contam Toxicol (1983) 0.83
Nerve growth factor-induced derepression of peripherin gene expression is associated with alterations in proteins binding to a negative regulatory element. Mol Cell Biol (1992) 0.83
Gene F of bacteriophage phiX174. Correlation of nucleotide sequences from the DNA and amino acid sequences from the gene product. J Mol Biol (1976) 0.82
The environmental and economic impact of removing growth-enhancing technologies from U.S. beef production. J Anim Sci (2012) 0.81
Characterization of novel akermanite:poly-ϵ-caprolactone scaffolds for human adipose-derived stem cells bone tissue engineering. J Tissue Eng Regen Med (2012) 0.81
Chronic administration of the oral hypoglycaemic agent diphenyleneiodonium to rats. An animal model of impaired oxidative phosphorylation (mitochondrial myopathy). Biochem Pharmacol (1988) 0.81
The mitochondrial myopathies. Defects of the mitochondrial respiratory chain and oxidative phosphorylation system. Electroencephalogr Clin Neurophysiol Suppl (1987) 0.81
Fos family members successively occupy the tyrosine hydroxylase gene AP-1 site after nerve growth factor or epidermal growth factor stimulation and can repress transcription. Mol Endocrinol (1994) 0.81
A 31P-n.m.r. study of the acute effects of beta-blockade on the bioenergetics of skeletal muscle during contraction. Biochem J (1987) 0.81
Altered transcriptional activity of c-fos promoter plasmids in v-raf-transformed NIH 3T3 cells. Mol Cell Biol (1990) 0.81
Regulation of cell proliferation and differentiation by Myc. J Cell Sci Suppl (1995) 0.80